Brad Martin

Brad Martin has a strong background in market access, trade, and distribution within the pharmaceutical industry. Brad currently holds the position of Head of Market Access and Trade at Neurotech Pharmaceuticals, Inc. starting in April 2023. Prior to this, they worked as the Vice President of Market Access, Specialty Trade & Distribution at Taysha Gene Therapies from March 2021 to the present. Brad'sresponsibilities at Taysha included building functional capabilities, strategic planning, and managing product distribution and channel strategy.

Before joining Taysha, Brad served as the Senior Director of Gene Therapy, Trade and Distribution at Sarepta Therapeutics from July 2019 to March 2021. In this role, they provided strategic direction for designing, implementing, and managing the trade and distribution channel for existing and pipeline products. Brad also worked closely with specialty distribution partners, established contracts, and served as the lead point of contact for trade-related activities.

Prior to their time at Sarepta, Brad worked as a National Account Director at AveXis, Inc. from March 2017 to July 2019. Brad also held the position of Regional Account Manager at Lundbeck from November 2011 to March 2017.

Overall, Brad Martin has a wealth of experience in market access, trade, and distribution, with a focus on strategic planning, product distribution, and channel strategy in the pharmaceutical industry.

Brad Martin attended Northeastern University from 1993 to 1998, where they earned a Bachelor's Degree in Athletic Training/Trainer.